“…Organizations and individuals in several countries immediately expressed an interest in endorsing and/or adapting the guideline for use in their jurisdictions given the extensive human, financial and technical resources required to create a de novo CPG. However, while guidelines in other chronic disease spaces such as lung cancer, psychosis, and rheumatology [ [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] ] have successfully demonstrated adaptation from one country to another, an adaptation of an obesity CPG had, to our knowledge, never been implemented.…”